As if we needed another reason to drink coffee or tea.
During a House committee meeting Tuesday, Kennedy announced a large-scale ad campaign from the federal government to hype wearable tech.
New research suggests the lack of a bacterium known to help infants digest breast milk could have significant consequences for the developing immune system.
Research out today is the latest to suggest that semaglutide can significantly lower people's risk of dementia.
The pharmaceutical company alleges Hims is widely selling cheaper versions of its blockbuster drugs, despite the FDA's recent mandate. Hims pushed back against the accusation.
Adults who reported weekly nightmares were more than three times as likely to die before the age of 70.
A French woman in her 60s is the only person in the world known to carry it so far.
Scientific organizations recently called for a 10-year ban on human germline editing. But will we ever be ready? And how would we even know?
A New Jersey man's unusual lung cancer may have been sparked by his decade-plus history of vaping.
In clinical trials, researchers found Yeztugo to be highly effective as a twice-yearly form of pre-exposure prophylaxis.
In early animal studies, the NXT-2 vaccine has looked effective against both life-threatening and common fungal infections.
New research finds that cannabis users are two times more likely to die from cardiovascular disease than non-users.
The latest covid variant, NB.1.8.1, is spreading fast and could fuel a summer surge.
Patients on GLP-1 medications lost about half as much weight as participants did in clinical trials, NYU researchers found.
A new study reveals that a woman's chances of getting asthma are significantly impacted by their work shift schedule—a difference that researchers didn't notice in men.
Millions of Americans are expected to lose their Medicaid coverage under the current version of the bill, and many will suffer or die as a result, a new analysis shows.
Medium-chain chlorinated paraffins (MCCPs) are already known to be toxic to aquatic life—now we're finding them in the air.
Turns out, NASA’s spectroscopic imaging tool, EMIT, can detect water pollution.
This treatment could benefit many different kinds of patients, but doctors will first need to address its unintended consequences.
Bill isn't buying what the MAHA movement is selling.
